Why the same gene linked to schizophrenia risk also shapes how some people physiologically respond to electromagnetic fields — and how that combination can distort interpretation
A growing body of human data is forcing a more nuanced conversation about electromagnetic field (EMF) effects and individual differences. At the center of that conversation is a single gene: CACNA1C, which encodes the main pore-forming subunit of the L-type voltage-gated calcium channel Cav1.2.
This gene is already one of the most robustly associated risk factors for schizophrenia and bipolar disorder. It is also emerging as a modulator of how the human nervous system responds to radiofrequency fields — and how people report sensitivity to those fields. The overlap is not trivial. It suggests a biological pathway that can simultaneously increase physiological reactivity to EMF and increase the likelihood that those real experiences will be interpreted through a fixed, persecutory lens.
Physiological evidence: genotype shapes EMF response
Two complementary human studies from the same research group make the physiological case.
In a 2025 double-blind, sham-controlled study published in NeuroImage, Sousouri and colleagues genotyped healthy volunteers for the common CACNA1C variant rs7304986 and exposed them to realistic 5G signals (3.6 GHz and 700 MHz) for 30 minutes before sleep. High-density EEG revealed a clear genotype-by-exposure interaction. Only T/C carriers showed a measurable acceleration of sleep-spindle center frequency during non-REM sleep after 3.6 GHz exposure. The shift was widespread across central, parietal, and occipital regions. T/T carriers did not show the same change. Critically, rs7304986 is a non-coding (intronic) variant. It does not alter the amino-acid sequence of the Cav1.2 channel itself. The protein is the same; what differs is the regulation of expression, timing, or density of the channels — in other words, how calcium signaling is handled.
An earlier observational study by Eicher and colleagues (published in Sleep Medicine) examined more than 2,000 participants. The T-allele of another CACNA1C variant, rs2302729, was associated with both reduced subjective sleep quality and higher rates of self-reported electromagnetic hypersensitivity. The same gene track appeared in both objective EEG responses to controlled RF exposure and in subjective reports of sensitivity.
These findings sit alongside cellular evidence that molecular background determines EMF outcome. In a 2026 Breast Journal study, the same ELF magnetic field produced dramatically different results across breast-cancer subtypes: HER2-enriched cells that failed to upregulate antioxidant genes (SODs) experienced large ROS increases and high rates of apoptosis, while other subtypes mounted protective antioxidant responses and largely resisted cell death. Genotype and molecular phenotype filtered the biological result of the identical physical exposure.
Taken together, the data support a simple but important principle: EMF effects are not uniform. They are filtered through the biology of the receiver — calcium-channel regulation, antioxidant capacity, and related pathways.
Psychiatric genetics: the same gene and delusional risk
CACNA1C is one of the strongest and most replicated genetic risk factors for schizophrenia and bipolar disorder from large genome-wide association studies. Common variants in the gene raise risk for these conditions; rare and de novo variants have been reported in individual patients with schizophrenia, some of whom presented with prominent persecutory delusions.
Schizophrenia frequently features persecutory delusions — fixed, false beliefs that one is being harmed, harassed, monitored, or plotted against by others. While CACNA1C is not specifically established as a risk gene for pure delusional disorder (a less-studied diagnosis), its robust link to schizophrenia means it contributes to the broader liability for forming and maintaining such beliefs.
The dual-pathway model
Here is where the two lines of evidence converge in a way that is scientifically coherent and clinically relevant.
A relevant CACNA1C background can produce two concurrent effects:
- Heightened physiological reactivity to radiofrequency fields. Real changes in sleep architecture, arousal, or somatic experience can occur when ambient RF rises. Meters may register elevated fields at the same time symptoms appear. The correlation can be genuine.
- Increased vulnerability to fixed persecutory interpretations. The same genetic influence that modulates calcium signaling and neuronal excitability also contributes to the risk architecture of schizophrenia, in which ambiguous or aversive internal experiences are more likely to be explained as intentional harm by external agents.
In this model, a person can experience authentic, genotype-linked physiological effects from ordinary or elevated environmental EMF and be biased by the same biology toward concluding that those effects are the result of deliberate targeting. The sensations are not invented. The explanatory system that turns them into “someone is on the roof beaming weapons at me” is where the psychiatric vulnerability becomes decisive.
This dual contribution does not require that EMF causes schizophrenia. It does not require that every report of electromagnetic hypersensitivity is psychotic. It simply recognizes that one gene can influence both the sensory/physiological side of the experience and the interpretive style that organizes it into a narrative of persecution.
What this does — and does not — mean
This framework has clear limits that must be stated plainly.
It does not validate claims of organized, deliberate electronic targeting of individuals by governments or coordinated groups using directed-energy weapons. Those specific narratives remain unsupported by credible evidence and frequently meet clinical criteria for persecutory delusions.
It does not mean that people who report EMF sensitivity are “just schizophrenic.” Most individuals with CACNA1C risk variants never develop schizophrenia, and many people who notice EMF-related symptoms do not form elaborate targeting beliefs.
It does suggest that a subgroup of people may sit at a particularly difficult intersection: measurable biological differences in how their nervous systems handle electromagnetic fields, combined with a genetic contribution to the kinds of fixed, false beliefs that turn those differences into a story of intentional harm. Online communities that reinforce targeting narratives can amplify the interpretive side of this process.
Implications for research and understanding
If genotype meaningfully shapes both physiological EMF response and the risk of persecutory ideation, then several practical consequences follow.
Research designs that treat “humans” as a single homogeneous category will continue to dilute real subgroup effects. Studies of EMF and sleep, cognition, or symptoms should genotype relevant variants whenever possible. Clinical evaluations of people reporting severe EMF-related distress or targeting beliefs should consider the possibility of genuine physiological contributions without automatically accepting the delusional explanatory system. And public discussion of electromagnetic hypersensitivity needs to move beyond the false choice between “it’s all in their heads” and “they are being deliberately attacked with secret weapons.”
The CACNA1C data point toward a third possibility: real biological differences in receiver physiology, operating in some individuals alongside a genetic predisposition that favors persecutory explanations of those differences. That combination is neither purely imaginary nor evidence of organized targeting. It is a testable interaction between genetics, environmental exposure, and cognitive interpretation — and it deserves careful, non-stigmatizing investigation.
References
Sousouri G, et al. 5G radio-frequency-electromagnetic-field effects on the human sleep electroencephalogram: A randomized controlled study in CACNA1C genotyped volunteers. NeuroImage. 2025;317:121340. https://doi.org/10.1016/j.neuroimage.2025.121340
Eicher C, et al. Reduced subjective sleep quality in people rating themselves as electro-hypersensitive: An observational study. Sleep Medicine. 2024;113:165-171. https://doi.org/10.1016/j.sleep.2023.11.029
Shayeghan M, et al. Pivotal Factors in Breast Cancer Molecular Subtypes Apoptosis Induction by ELF-EMF; Ki-67, ROS Level, HER-2, and SODs. The Breast Journal. 2026. https://doi.org/10.1155/tbj/9572421
(Large-scale GWAS literature establishing CACNA1C as a risk gene for schizophrenia and bipolar disorder is extensively reviewed in the psychiatric genetics literature and is not re-cited here in full.)
